GCVCX
Price
$23.09
Change
-$0.04 (-0.17%)
Updated
Jun 5 closing price
Net Assets
515.73M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

GCVCX vs RMEBX

Header iconGCVCX vs RMEBX Comparison
Open Charts GCVCX vs RMEBXBanner chart's image
Goldman Sachs Large Cp Val Insghts C
Price$23.09
Change-$0.04 (-0.17%)
VolumeN/A
Net Assets515.73M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
GCVCX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCVCX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVCX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. GCVCX (516M). RMEBX pays higher dividends than GCVCX: RMEBX (1.16) vs GCVCX (0.19). GCVCX was incepted earlier than RMEBX: GCVCX (26 years) vs RMEBX (11 years). GCVCX (1.77) is less costly to investors than RMEBX (1.07). GCVCX is a more actively managed with annual turnover of: 206.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than GCVCX: RMEBX (250) vs GCVCX (1000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. GCVCX (-3.91). RMEBX return over 5 years is better than : 49.85 vs. GCVCX (18.20).
GCVCXRMEBXGCVCX / RMEBX
Total Expense Ratio1.671.07156%
Annual Report Gross Expense Ratio1.771.07165%
Fund Existence26 years11 years-
Gain YTD1.0695.34920%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets516M105B0%
Annual Yield % from dividends0.191.1616%
Returns for 1 year-3.918.30-47%
Returns for 3 years5.5217.9631%
Returns for 5 years18.2049.8537%
Returns for 10 years41.8368.2161%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA